4045-302. A Long-term, Open-label Extension Study for Patients with Duchenne Muscular Dystrophy Enrolled in Clinical Trials Evaluating Casimersen or Golodirsen

Project: Research project

Project Details

StatusActive
Effective start/end date8/3/188/31/50

Funding

  • Sarepta Therapeutics, Inc.
  • Sarepta Therapeutics, Inc.